Skip to content

Clinical trials

Lung Diseases, Interstitial trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Unknown status Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20164
20171
20181
20193
20202
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangzhou Institute of Respiratory Disease4
Qilu Hospital of Shandong University2
China-Japan Friendship Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
Nanfang Hospital, Southern Medical University1
Peking Union Medical College Hospital1
RenJi Hospital1
Shandong Cancer Hospital and Institute1
Shanghai Pulmonary Hospital, Shanghai, China1
Shanghai University of Traditional Chinese Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial18
Arthritis, Rheumatoid3
Myositis3
Connective Tissue Diseases2
Dermatomyositis2
Scleroderma, Systemic2
Airway Obstruction1
Anemia1
Asthma1
Bronchiolitis Obliterans1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.